搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
腾讯网
13 天
免疫治疗“王炸组合”!细胞治疗联合PD-1/PD-L1治疗肿瘤,或将改变 ...
免疫疗法(Immunotherapy)是指人体利用免疫系统对抗疾病的疗法,肿瘤免疫疗法就是以免疫系统作为武器抗击癌症。免疫系统是由器官、组织、特殊细胞以及保护人体抵御感染和疾病的物质集合。正常情况下,免疫系统可以自行处理癌细胞,如:摧毁肿瘤或使其保持生长。但免疫系统有时也会识别失败——因为一个肿瘤生长得过大,癌 ...
Armed robbery in Revesby
4 天
Melanoma Tool May Guide Immunotherapy Decisions
Dana-Farber Cancer Institute authors: Giuseppe Tarantino, PhD, David Liu, MD, MPH ...
emjreviews.com
6 天
New Combination Therapy Shows Promise for Neuroendocrine Cancers
Discover a recent clinical trial that explored the efficacy of combining pembrolizumab, an anti-PD-1 immunotherapy, with ...
BioSpace
12 天
Merck’s Subcutaneous Keytruda Meets Expectations in Phase III
Analysts are split on whether the positive trial results will help Merck stem future Keytruda losses as the mega-blockbuster ...
3 天
Replimune: RPL1 BLA Submission Under AA Pathway Makes It A Must Watch
Replimune's BLA submission and promising pipeline drugs are set to impact the global melanoma therapeutics market. Read more ...
5 天
Compugen Bolsters Cancer Therapy Portfolio with New Patent
Compugen (CGEN) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - Now At 40% ...
News Medical on MSN
2 天
Phase 1 study finds serine- and glycine-free diet boosts immune response in colorectal cancer
Findings indicate a serine/glycine-free diet can reduce colorectal cancer growth and enhance immune response, offering ...
Targeted Oncology
5 天
FDA Receives BLA for RP1 and Nivolumab Combo in Advanced Melanoma
The FDA has received a biologics license application submission for RP1 plus nivolumab in patients with PD-1 ...
Business Wire
8 天
TME Pharma Announces Poster Presentation by U.S. National Cancer Institute on CXCL12 ...
TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies ...
GEN
4 天
Rare Genetic Disorder Helps Explain Link Between Cancer Immunotherapy and Increased Infections
Studying patients with PD-1 or PD-L1 deficiency may help inform new approaches to fine-tuning immunotherapies to maximise ...
oncnursingnews
7 天
Accelerated Approval Sought for RP1-Nivolumab Combo for Pretreated Melanoma
The FDA received a biologics license application for accelerated approval of RP1 plus nivolumab for advanced, pretreated ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈